Ana Maria Mihalcea promotes EDTA infusions, also for children!

Bryan Ardis recommends the #EDTA oral pills that contain a Pfizer patent with "timed-release" technology and biosesors for internal tracking!

So let's get into it!

EDTA patent:
https://patents.google.com/patent/WO2005027832A2/en

The patent contains a drug delivery system and controlled release nanotechnology called Eudragit-L-100 NF which are coated nanoparticles.

https://pubmed.ncbi.nlm.nih.gov/27525928/

The EDTA pill patent also contains an ACE inhibitor, a calcium channel blocker and a chlorophyll synthesis blocker. 
Calcium Channel Blockers prevent calcium from interacting with the body’s calcium receptors and inhibits the influx of calcium ions into muscle cells. This can cause stiffness in muscles, loss of muscle control and even seizures.
Chlorophyll synthesis blockers prevent the body from generating new red blood cells. And that is a huge problem since the COVID nanotech is destroying red blood cells.

EDTA contains one of the most toxic Beta Blockers called Propranolol, a sodium channel blocker that also crosses the blood-brain barrier.

The EDTA patent also states that it causes the body to dump salt and water, inducing dehydration.

A 10-year review (2006 to 2015) of "double-dose" ingestions from the California Poison Control System revealed that antihypertensives like beta-blockers and calcium channel blockers caused moderate to severe effects in 37 percent of cases.

https://www.uptodate.com/contents/beta-blocker-poisoning

EDTA contains Aluminium in a form of Alumina which is a synthetically produced aluminum oxide. EDTA also contains Aluminum Stearate which is an aluminum salt of stearic acid. These are toxic metals.

EDTA contains D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) which is widely applied as a multifunctional drug carrier for nanomedicine. 

EDTA also contains “human serum albumin,” a protein found in human blood.

https://t.me/c/2089089872/2110
Ana Maria Mihalcea promotes EDTA infusions, also for children! Bryan Ardis recommends the #EDTA oral pills 💊 that contain a Pfizer patent with "timed-release" technology and biosesors for internal tracking! So let's get into it! EDTA patent: https://patents.google.com/patent/WO2005027832A2/en The patent contains a drug delivery system and controlled release nanotechnology called Eudragit-L-100 NF which are coated nanoparticles. https://pubmed.ncbi.nlm.nih.gov/27525928/ The EDTA pill patent also contains an ACE inhibitor, a calcium channel blocker and a chlorophyll synthesis blocker.  Calcium Channel Blockers prevent calcium from interacting with the body’s calcium receptors and inhibits the influx of calcium ions into muscle cells. This can cause stiffness in muscles, loss of muscle control and even seizures. Chlorophyll synthesis blockers prevent the body from generating new red blood cells. And that is a huge problem since the COVID nanotech is destroying red blood cells. EDTA contains one of the most toxic Beta Blockers called Propranolol, a sodium channel blocker that also crosses the blood-brain barrier. The EDTA patent also states that it causes the body to dump salt and water, inducing dehydration. A 10-year review (2006 to 2015) of "double-dose" ingestions from the California Poison Control System revealed that antihypertensives like beta-blockers and calcium channel blockers caused moderate to severe effects in 37 percent of cases. https://www.uptodate.com/contents/beta-blocker-poisoning EDTA contains Aluminium in a form of Alumina which is a synthetically produced aluminum oxide. EDTA also contains Aluminum Stearate which is an aluminum salt of stearic acid. These are toxic metals. EDTA contains D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) which is widely applied as a multifunctional drug carrier for nanomedicine.  EDTA also contains “human serum albumin,” a protein found in human blood. 😱 https://t.me/c/2089089872/2110
WO2005027832A2 - Edta containing compositions and uses thereof - Google Patents
EDTA and EDTA related compositions and methods of using them are described herein. The compositions can have improved bioavailability over EDTA alone. The compositions can be useful in the treatment or prevention of atherosclerosis or for the treatment of heavy metal accumulation.
0 Comments 0 Shares 3514 Views